Hamlet Biopharma
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Klinikgatan 32, Lund, 222 42, SwedenPhone Number
+46 40122500Website
www.hamletbiopharma.comRevenue
$5.4 MillionIndustry
About Hamlet Biopharma
Is Hamlet Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Hamlet Biopharma launches new products
Hamlet Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Hamlet Biopharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Hamlet Biopharma recently announced quarterly report
Check out if Hamlet Biopharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Hamlet Biopharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Hamlet Biopharma
Funding: Get notified immidiatlly once Hamlet Biopharma has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Hamlet Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hamlet Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hamlet Biopharma.
Hamlet Biopharma News & Media
Hamlet BioPharma Announces the Completion of the Alpha1H Phase II Study in Non-Muscle Invasive Bladder Cancer
LUND, Sweden, Aug. 21, 2025 /PRNewswire/ -- Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the completion of the successful Phase II clinical trial of the company's drug candidate Alpha1H in patients with cancer...Hamlet BioPharma Holds Successful In Person Meeting with US FDA
LUND, Sweden, June 25, 2025 /PRNewswire/ -- Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, today announces the successful first in-person meeting with the U.S. Food and Drug Administration (FDA). The meeting was held on...Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s Life Science Investor Konference held in Copenhagen on November 27th 2024. Økonomisk Ugebrev, serves as a platform for collaboration and investment opportunities. Hamlet BioPharma presented the advances made by the company to a diverse audience and the presentation was followed by lively discussions. The video from the event is now available on HamHamlet BioPharma Participates in the BioStock Life Science Summit 2024
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces its participation in the BioStock Life Science Summit, set to take place in Lund, Sweden, on November 20-21, 2024. The company will present at 1:30 pm on Wednesday the 20th of November. For more information about BioStock Life Science Summit 2024, please visit BioStock Life Science Summit 2024 (https://www.biostock.se/summit-2024/) web page. For further information, please
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hamlet Biopharma
Hamlet Biopharma is an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.... Read More